Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality

被引:6
|
作者
Mendes, Leandro C. [1 ]
Ferreira, Paulo A. [2 ]
Miotto, Noelle [1 ]
Zanaga, Leticia [1 ]
Lazarini, Maria S. [1 ]
Goncales, Eduardo S. L. [1 ]
Pedro, Marcelo N. [1 ]
Goncales, Fernando L. [1 ]
Stucchi, Raquel S. B. [1 ]
Vigani, Aline G. [1 ]
机构
[1] Univ Estadual Campinas, Dept Infect Dis, Campinas, SP, Brazil
[2] Univ Fed Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil
关键词
accuracy; controlled attenuation parameter; elastography; morphometry; quality; steatosis; FATTY LIVER; SONOGRAPHIC ASSESSMENT; DIAGNOSIS; VARIABILITY; ACCURACY; DISEASE; INTRAOBSERVER; INTEROBSERVER; VALIDITY; FIBROSIS;
D O I
10.1097/MEG.0000000000001145
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and objective Controlled attenuation parameter (CAP) diagnostic performance for steatosis grading has been controversial and considerable observer-related variability in liver biopsy has been reported. This is a subanalysis of a larger chronic hepatitis C study on noninvasive fibrosis staging. Materials and methods Patients were prospectively enrolled for paired liver biopsy and transient elastography. Biopsy fragments were subjected to digital morphometric steatosis quantification. Associated patient and technical factors, including a newly described elastogram quality score, were evaluated. Results A total of 312 patients were included in the final analysis. The mean liver stiffness was 8.7 +/- 2.1 kPa. Morphometry showed S0 in 19.2% of patients, S1 in 28.5%, S2 in 31.1%, and S3 in 21.2%. CAP showed S0 in 11.2% of patients, S1 in 26.6%, S2 in 56.7%, and S3 in 5.4%. Spearman coefficient showed a positive and independent correlation between CAP and morphometric analysis (r = 0.48, P < 0.05), except for distinguishing S1 and S2 (P = 0.11). Area under the receiver operating characteristic curves for the presence or absence of steatosis was 0.944; differentiation between levels I, II, and III were 0.776, 0.812, and 0.879. Elastogram quality independently predicted accuracy [odds ratio (OR): 6.95, 95% confidence interval (95% CI): 4.45-9.06 as well as CAP interquartile range OR: 2.81, 95% CI: 1.67-3.99] and liver stiffness (OR: 0.78, 95% CI: 0.51-0.80). Conclusion We present an external validation for CAP against the objective steatosis quantification provided by digital morphometry. Fairly good performance indicators were found, except for S1 versus S2 differentiation. Variability and higher liver stiffness were associated with lower performance. Achieving higher quality measurements, however, overcame such limitations with excellent accuracy. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:959 / 966
页数:8
相关论文
共 26 条
  • [21] An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C
    O'Brien, MJ
    Keating, NM
    Elderiny, S
    Cerda, S
    Keaveny, AP
    Afdhal, NH
    Nunes, DP
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (05) : 712 - 718
  • [22] The impact of single-nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct-acting antiviral drugs for hepatitis C infection
    Matsumoto, Kosuke
    Miyaaki, Hisamitsu
    Fukushima, Masanori
    Sasaki, Ryu
    Haraguchi, Masafumi
    Miuma, Satoshi
    Nakao, Kazuhiko
    BIOMEDICAL REPORTS, 2022, 16 (02)
  • [23] The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals
    Lee, Yu-Chi
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Lu, Sheng-Nan
    Chen, Chien-Hung
    Wang, Jing-Houng
    PLOS ONE, 2019, 14 (04):
  • [24] Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP)
    Cespiati, Annalisa
    Petta, Salvatore
    Lombardi, Rosa
    Di Marco, Vito
    Calvaruso, Vincenza
    Bertelli, Cristina
    Pisano, Giuseppina
    Fatta, Erika
    Sigon, Giordano
    Iuculano, Federica
    Crapanzano, Luciano
    Gibilaro, Gerlando
    Francione, Paolo
    Craxi, Antonio
    Fargion, Silvia
    Fracanzani, Anna Ludovica
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (10) : 1301 - 1307
  • [25] Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
    Ragazzo, Taisa Grotta
    Paranagua-Vezozzo, Denise
    Lima, Fabiana Roberto
    de Campos Mazo, Daniel Ferraz
    Pessoa, Mario Guimaraes
    Oliveira, Claudia Pinto
    Ferreira Alves, Venancio Avancini
    Carrilho, Flair Jose
    CLINICS, 2017, 72 (09) : 516 - 525
  • [26] Impact of liver-stiffness measurement on hepatocellular carcinoma development in chronic hepatitis C patients treated with direct-acting antivirals: A systematic review and time-to-event meta-analysis
    You, Myung-Won
    Kim, Kyung Won
    Shim, Jae-Jun
    Pyo, Junhee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (03) : 601 - 608